A new mathematical model to identify contacts with recent and remote latent tuberculosis.


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 26 03 2019
accepted: 10 04 2019
entrez: 18 6 2019
pubmed: 18 6 2019
medline: 18 6 2019
Statut: epublish

Résumé

Tuberculosis (TB) elimination programmes need to target preventive treatment to groups with an increased risk of TB activation, such as individuals with a latent tuberculosis infection (LTBI) acquired recently. Current diagnostic tests for LTBI have poor predictive values for TB activation and there is, at present, no reference method to evaluate new LTBI diagnostic and prognostic tools. Thus, our objective was to develop a mathematical model, independent of currently available diagnostic tests, to estimate the individual probability of recent and/or remote LTBI. Estimations of recent LTBI were based on the contagiousness of index case, proximity and time of exposure, and environmental factors. Estimation of remote LTBI was based on country of origin, previous stays in high-risk environments or known exposure to TB. Individual probabilities were calculated and compared with tuberculin skin test (TST) and interferon-γ release assay results for 162 contacts of 42 index TB cases. Probabilities of remote LTBI were 16% for European/American contacts and 38% for African/Asian contacts. The probability of recent LTBI was 35% for close contacts to smear microscopy positive index cases. A higher probability of remote LTBI was seen among TST-positive contacts. This model may, with further validation, be used as an independent tool to evaluate new diagnostic markers for recent LTBI.

Identifiants

pubmed: 31205929
doi: 10.1183/23120541.00078-2019
pii: 00078-2019
pmc: PMC6556559
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Conflict of interest: G. Fröberg has nothing to disclose. Conflict of interest: E. Wahren Borgström has nothing to disclose. Conflict of interest: E. Chryssanthou has nothing to disclose. Conflict of interest: M. Correia-Neves has nothing to disclose. Conflict of interest: G. Källenius has nothing to disclose. Conflict of interest: J. Bruchfeld has nothing to disclose.

Références

Nat Genet. 1999 May;22(1):59-62
pubmed: 10319862
JAMA. 1999 Aug 18;282(7):677-86
pubmed: 10517722
Am J Respir Crit Care Med. 2000 Dec;162(6):2033-8
pubmed: 11112109
JAMA. 2002 Feb 27;287(8):996-1002
pubmed: 11866647
Bull Int Union Tuberc. 1975;50(1):90-106
pubmed: 1218291
Altern Med Rev. 2003 Aug;8(3):223-46
pubmed: 12946237
J Bacteriol. 1958 Nov;76(5):471-84
pubmed: 13598704
Am J Respir Crit Care Med. 2004 Mar 1;169(5):604-9
pubmed: 14656754
Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S363-8
pubmed: 14677824
J Occup Environ Hyg. 2005 Mar;2(3):143-54
pubmed: 15764538
Clin Dermatol. 2006 Mar-Apr;24(2):84-7
pubmed: 16487878
Lancet Infect Dis. 2008 Apr;8(4):233-43
pubmed: 18201929
Bull World Health Organ. 2008 Jan;86(1):4
pubmed: 18235879
Swiss Med Wkly. 2008 Feb 9;138(5-6):78-84
pubmed: 18293115
Int J Tuberc Lung Dis. 2008 May;12(5):498-505
pubmed: 18419884
J Aerosol Med Pulm Drug Deliv. 2009 Sep;22(3):229-37
pubmed: 19415984
Clin Chest Med. 2009 Dec;30(4):621-36, vii
pubmed: 19925958
Expert Rev Respir Med. 2009 Jun;3(3):309-27
pubmed: 20477323
Eur Respir J. 2010 Oct;36(4):925-49
pubmed: 20889463
Chest. 2012 Jul;142(1):63-75
pubmed: 22490872
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am J Respir Crit Care Med. 2012 Sep 1;186(5):450-7
pubmed: 22798319
Int J Tuberc Lung Dis. 2012 Nov;16(11):1477-84
pubmed: 22964038
Am J Respir Crit Care Med. 2013 May 1;187(9):1007-15
pubmed: 23306539
Curr HIV/AIDS Rep. 2013 Sep;10(3):264-72
pubmed: 23824469
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76
pubmed: 25303140
Front Immunol. 2015 Jun 29;6:313
pubmed: 26175730
Am J Respir Crit Care Med. 2017 Sep 1;196(5):638-648
pubmed: 28737960
Thorax. 2018 Apr 5;:null
pubmed: 29622693
Front Immunol. 2018 Apr 10;9:709
pubmed: 29692778
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
J Appl Physiol (1985). 1963 May 01;18(3):519-522
pubmed: 31094493
Thorax. 1982 Nov;37(11):840-4
pubmed: 7164002
Clin Infect Dis. 1996 Nov;23(5):954-62
pubmed: 8922785

Auteurs

Gabrielle Fröberg (G)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Emilie Wahren Borgström (E)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Erja Chryssanthou (E)

Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.

Margarida Correia-Neves (M)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.

Gunilla Källenius (G)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Judith Bruchfeld (J)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH